(Q54597465)

1 June 2018

title

Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha. (English)

1 reference

1 June 2018

0 references

0 references

Steven McFarlane

1

1 reference

1 June 2018

Mary Jane Nicholl

series ordinal

2

1 reference

1 June 2018

Jane S Sutherland

series ordinal

3

1 reference

1 June 2018

Chris M Preston

series ordinal

4

1 reference

1 June 2018

language of work or name

English

0 references

publication date

8 April 2011

1 reference

1 June 2018

published in

Virology

1 reference

1 June 2018

volume

414

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

83-90

1 reference

1 June 2018

Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Mechanism of activation and function of protein kinase B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

7 January 2021

The two TORCs and Akt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Key factors in mTOR regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

PIKKing on PKB: regulation of PKB activity by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

A subset of viral transcripts packaged within human cytomegalovirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Genetic content of wild-type human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Specific chromosome 1 breaks induced by human cytomegalovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Nutrient sensing and inflammation in metabolic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Transcriptome analysis of fibroblast cells immediate-early after human cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Activity and intracellular localization of the human cytomegalovirus protein pp71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1 and Stimulates the Synthesis of Vascular Endothelial Growth Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Differential modification of interferon regulatory factor 3 following virus particle entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Stress and mTORture signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1 -Mediated Glycolytic Adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Beta interferon production in primed and unprimed cells infected with human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hypoxia-inducible factor 1: master regulator of O2 homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human Cytomegalovirus: Purification of Enveloped Virions and Dense Bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Regulation of hypoxia-inducible factor-1alpha by NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

The HIF/VHL pathway: from oxygen sensing to innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Hypoxia inducible factor (HIF) function in innate immunity and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

Temporal Patterns of Human Cytomegalovirus Transcription: Mapping the Viral RNAs Synthesized at Immediate Early, Early, and Late Times After Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.03.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2011.03.005

1 reference

1 June 2018

1 reference

1 June 2018